Clinical Network Services Pty Ltd Appoints Leading Toxicologist Douglas Francis to BioDesk
Clinical Network Services (CNS), an Australian based CRO offering integrated development services in the planning, implementation and delivery of Phase 1 and 2 trials, today announced that it has appointed ex-Therapeutic Goods Administration (TGA) toxicologist, Dr Douglas Francis, as Senior Regulatory Toxicologist to the Company’s BioDesk product development planning and regulatory affairs service.